<?xml version="1.0" encoding="UTF-8"?>
<abstract id="16861255">
  <title>
    <s id="0" section="title">
      Prevention of
      <outcome id="0">postoperative  nausea  and  vomiting</outcome>
      by metoclopramide combined with dexamethasone : randomised double blind multicentre trial .
    </s>
  </title>
  <annotated>
    <s id="1" section="objectives">
      To determine whether
      <group id="1">10  mg</group>
      ,
      <group id="2">25  mg</group>
      , or
      <group id="3">50  mg  metoclopramide  combined  with  8  mg  dexamethasone</group>
      , given intraoperatively , is more effective in preventing
      <outcome id="0">postoperative  nausea  and  vomiting</outcome>
      than
      <group id="4">8  mg  dexamethasone  alone</group>
      , and to assess benefit in relation to
      <outcome id="1">adverse  drug  reactions</outcome>
      .
    </s>
    <s id="2" section="design">4 -armed , parallel group , double blind , randomised controlled clinical trial .</s>
    <s id="3" section="setting">4 clinics of a university hospital and 4 district hospitals in Germany .</s>
    <s id="4" section="participants">
      <ps>3140</ps>
      patients who received balanced or regional anaesthesia during surgery .
    </s>
    <s id="5" section="main__outcome_measures">
      <outcome id="0">
        <short>Postoperative  nausea  and  vomiting</short>
        within
        <time id="0">24  hours  of  surgery</time>
      </outcome>
      ( primary end point ) ;
      <outcome id="1">
        occurrence  of
        <short>adverse  reactions</short>
      </outcome>
      .
    </s>
    <s id="6" section="results">
      <outcome id="0">
        Cumulative  incidences  (  95  %  confidence  intervals  )  of
        <short>postoperative  nausea  and  vomiting</short>
      </outcome>
      were 23.1 % ( 20.2 % to 26.0 % ) , 20.6 % ( 17.8 % to 23.4 % ) , 17.2 % ( 14.6 % to 19.8 % ) , and 14.5 % ( 12.0 % to 17.0 % ) for
      <group id="4">0  mg</group>
      ,
      <group id="1">10  mg</group>
      ,
      <group id="2">25  mg</group>
      , and
      <group id="3">50  mg  metoclopramide</group>
      .
    </s>
    <s id="7" section="results">
      In the secondary analysis ,
      <group id="2">25  mg</group>
      and
      <group id="3">50  mg  metoclopramide</group>
      were equally effective at
      <outcome id="0:0">preventing  early  nausea</outcome>
      ( 0 -12 hours ) , but only
      <group id="3">50  mg</group>
      reduced
      <outcome id="0:1">late  nausea  and  vomiting</outcome>
      ( &gt; 12 hours ) .
    </s>
    <s id="8" section="results">
      The most frequent adverse drug reactions were
      <outcome id="1:0">hypotension</outcome>
      and
      <outcome id="1:1">tachycardia</outcome>
      , with cumulative incidences of 8.8 % ( 6.8 % to 10.8 % ) , 11.2 % ( 9.0 % to 13.4 % ) , 12.9 % ( 10.5 % to 15.3 % ) , and 17.9 % ( 15.2 % to 20.6 % ) for
      <group id="4">0  mg</group>
      ,
      <group id="1">10  mg</group>
      ,
      <group id="2">25  mg</group>
      , and
      <group id="3">50  mg  metoclopramide</group>
      .
    </s>
    <s id="9" section="conclusion">
      The
      <group id="3">
        addition  of
        <short>50  mg  metoclopramide  to  8  mg  dexamethasone</short>
      </group>
      ( given intraoperatively ) is an effective , safe , and cheap way to prevent
      <outcome id="0">postoperative  nausea  and  vomiting</outcome>
      .
    </s>
    <s id="10" section="conclusion">
      <group id="5">
        A  reduced  dose  of
        <short>25  mg  metoclopramide  intraoperatively  ,  with  additional  postoperative  prophylaxis</short>
      </group>
      in high risk patients , may be equally effective and cause fewer
      <outcome id="1">adverse  drug  reactions</outcome>
      .
    </s>
  </annotated>
  <fulltext>Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone : randomised double blind multicentre trial . To determine whether 10 mg , 25 mg , or 50 mg metoclopramide combined with 8 mg dexamethasone , given intraoperatively , is more effective in preventing postoperative nausea and vomiting than 8 mg dexamethasone alone , and to assess benefit in relation to adverse drug reactions . 4 -armed , parallel group , double blind , randomised controlled clinical trial . 4 clinics of a university hospital and 4 district hospitals in Germany . 3140 patients who received balanced or regional anaesthesia during surgery . Postoperative nausea and vomiting within 24 hours of surgery ( primary end point ) ; occurrence of adverse reactions . Cumulative incidences ( 95 % confidence intervals ) of postoperative nausea and vomiting were 23.1 % ( 20.2 % to 26.0 % ) , 20.6 % ( 17.8 % to 23.4 % ) , 17.2 % ( 14.6 % to 19.8 % ) , and 14.5 % ( 12.0 % to 17.0 % ) for 0 mg , 10 mg , 25 mg , and 50 mg metoclopramide . In the secondary analysis , 25 mg and 50 mg metoclopramide were equally effective at preventing early nausea ( 0 -12 hours ) , but only 50 mg reduced late nausea and vomiting ( &gt; 12 hours ) . The most frequent adverse drug reactions were hypotension and tachycardia , with cumulative incidences of 8.8 % ( 6.8 % to 10.8 % ) , 11.2 % ( 9.0 % to 13.4 % ) , 12.9 % ( 10.5 % to 15.3 % ) , and 17.9 % ( 15.2 % to 20.6 % ) for 0 mg , 10 mg , 25 mg , and 50 mg metoclopramide . The addition of 50 mg metoclopramide to 8 mg dexamethasone ( given intraoperatively ) is an effective , safe , and cheap way to prevent postoperative nausea and vomiting . A reduced dose of 25 mg metoclopramide intraoperatively , with additional postoperative prophylaxis in high risk patients , may be equally effective and cause fewer adverse drug reactions . Current Controlled Trials ISRCTN31625370 [ controlled - trials .com ] .</fulltext>
  <ignored>
    <s id="11" section="trial_registration">Current Controlled Trials ISRCTN31625370 [ controlled - trials .com ] .</s>
  </ignored>
</abstract>

